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ARTICLE
Every-other-day feeding extends lifespan but fails
to delay many symptoms of aging in mice
Kan Xie et al.#
Dietary restriction regimes extend lifespan in various animal models. Here we show that
longevity in male C57BL/6J mice subjected to every-other-day feeding is associated with a
delayed onset of neoplastic disease that naturally limits lifespan in these animals. We
compare more than 200 phenotypes in over 20 tissues in aged animals fed with a lifelong
every-other-day feeding or ad libitum access to food diet to determine whether molecular,
cellular, physiological and histopathological aging features develop more slowly in every-
other-day feeding mice than in controls. We also analyze the effects of every-other-day
feeding on young mice on shorter-term every-other-day feeding or ad libitum to account for
possible aging-independent restriction effects. Our large-scale analysis reveals overall only
limited evidence for a retardation of the aging rate in every-other-day feeding mice. The data
indicate that every-other-day feeding-induced longevity is sufﬁciently explained by delays in
life-limiting neoplastic disorders and is not associated with a more general slowing of the
aging process in mice.
DOI: 10.1038/s41467-017-00178-3 OPEN
Correspondence and requests for materials should be addressed to
D.E. (email: Dan.Ehninger@dzne.de). #A full list of authors and their afﬂiations appears at the end of the paper.
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Aging is a major risk factor for most adult-onset disordersand is associated with a broad range of functionalimpairments1. Targeting aging processes with suitable
pharmacological or dietary approaches could potentially repre-
sent a powerful inroad for the development of preventatives for
aging-associated disorders2.
The majority of studies performed to date to identify novel
anti-aging interventions employed lifespan measures as a primary
readout to detect effects on aging. Dietary restriction (DR) regi-
mens are among the most extensively documented experimental
interventions with longevity effects in a number of different
species, including various invertebrate (e.g., Caenorhabditis ele-
gans and Drosophila melanogaster), as well as vertebrate species
(such as Rattus rattus, Mus musculus, and Bos taurus)3.
Longevity effects have been demonstrated for different DR
paradigms, including caloric restriction (CR)4–7 and restriction
regimens associated with intermittent periods of fasting, such as
every-other-day feeding (EOD)8, 9. In the context of CR experi-
ments, restricted animals are provided with a speciﬁed proportion
(e.g., 60%) of the amount of food consumed by animals with ad
libitum access to food (AL, i.e., by the control group). In inter-
mittent fasting (IF) paradigms, food is provided generally AL to
both controls and restricted mice, but restricted mice are, unlike
controls, subjected to intermittent periods of fasting (IF); one
speciﬁc IF protocol is EOD that alternates 24-h periods of full
starvation and AL access to food. EOD extends lifespan without a
substantial decrease of average daily food intake10. While life-
extending effects of CR are correlated positively with the degree
of food deprivation (up to 60%)7, EOD extends average lifespan
between 12 and 27% in mice if initiated early in life7, 9. The effects
of CR on lifespan and age-related changes have been extensively
studied over the past decades3, 11, but much less attention has
been paid to EOD.
In order to systematically study EOD’s effects on aging and
lifespan, we performed a large-scale analysis of >200 molecular,
cellular, histopathological, and physiological parameters across
>20 different tissues in mice subjected to EOD or AL access to
food for much of their lifetime. The parameters selected corre-
sponded in large part to the ones used in our prior large-scale
analysis of rapamycin’s effects on aging in male C57BL/6J mice12.
In addition to the analyses of aging phenotypes, we determined
EOD’s effects on lifespan and assessed causes of natural death in
cohorts chronically subjected to EOD or AL.
Our data show that lifespan extension induced by EOD in male
C57BL/6J mice is sufﬁciently explained by a delay in life-limiting
neoplastic disorders. Our large-scale analysis of molecular, cel-
lular, physiological, and histopathological aging phenotypes
identiﬁed only few aging features delayed by EOD, indicating that
the observed extension in lifespan was not associated with a more
general slowing of aging processes in EOD mice.
Results
EOD extended lifespan and delayed lethal neoplastic disease.
Over the course of their entire lifespan, average calorie intake of
EOD mice was reduced by 7.5% (controls: 11.06 kcal/day; EOD:
10.23 kcal/day) (Fig. 1b). Body weights remained reduced in EOD
mice during much of their adult life (average reduction of
~17.1%) (Fig. 1c). Organ weights and body dimensions were
often reduced in EOD mice compared to AL controls (Supple-
mentary Fig. 1). Consistent with prior ﬁndings9, we observed
signiﬁcant lifespan extension in EOD mice (Fig. 1d). Mean life-
span was prolonged by 102 days (AL: 806 days, EOD: 908 days)
and maximum lifespan, calculated based on the longest living
20%, was extended by 122 days (AL: 980 days, EOD: 1102 days)
(Fig. 1e), which is within the range of lifespan extension observed
in previous DR studies13. Calculation of mortality doubling time
using the Gompertz function revealed no substantial difference
between AL and EOD animals (AL: 83.6 days, EOD: 91.7 days).
A detailed pathological examination of dead mice revealed that
most EOD and AL mice had died of neoplastic disorders (Fig. 1f),
most notably hematological malignancies, known leading natural
causes of death in both sexes of many inbred mouse strains,
including C57BL/6J6, 14. Though cancer remained unchanged as
the primary cause of death, tumor burden at death was sig-
niﬁcantly reduced in EOD mice compared to controls (average
number of tumors per mouse: AL= 1.28, EOD= 0.85) (Fig. 1g
and Supplementary Table 1). The ﬁndings indicate that EOD
mice lived longer than controls because lethal neoplastic disease
was delayed in these animals.
Large-scale phenotyping to assess EOD effects on aging. In
order to systematically study EOD’s effects on aging and lifespan,
we performed a large-scale analysis of >200 molecular, cellular,
histopathological, and physiological parameters across >20 dif-
ferent tissues in mice subjected to EOD or AL access to food for
much of their lifetime. To be able to account for acute EOD
effects, our study design included young groups of mice subjected
to EOD or AL for only 1 month prior to the commencement of
phenotypic analyses at 3 months of age (Fig. 1a).
On the basis of their modulation by age (old vs. young) and/or
diet (EOD vs. AL), traits from the large-scale phenotypic analyses
were categorized as follows: (i) aging phenotypes prevented or
delayed by EOD (Supplementary Table 2). These were aging
phenotypes that were speciﬁcally rescued by EOD in the aged
group of mice kept on almost lifelong EOD but that remained
unaltered in young mice on short-term treatment; (ii) age-
sensitive parameters opposed by EOD with similar outcomes in
young and old mice (Supplementary Table 3). Similar EOD effects
on a trait in both young mice on short-term treatment, and aged
mice subjected to EOD for much of their lifetime, cannot be taken as
evidence that EOD prevented or delayed aging; (iii) aging
phenotypes not measurably altered or worsened by EOD (Supple-
mentary Table 4); (iv) parameters modulated by EOD but not by age
(Supplementary Table 5); (v) traits neither modiﬁed by aging nor by
EOD. Experimental ﬁndings regarding aging-associated phenotypes
are described in the remainder of the “Results” section, in Figs. 2–7,
Supplementary Tables 6–17, as well as Supplementary Data sets 1
and 2. A summary of the ﬁndings is provided in the concluding
section of the “Results” section and in Fig. 1h–j.
EOD had age-independent effects on neurological phenotypes.
We started our analysis of age-related health parameters by
testing neurological and behavioral functions in aged mice sub-
jected to almost lifelong EOD or AL access to food, as well as
young mice on short-term EOD or AL. If not stated otherwise, all
measurements were initiated in the morning after a feeding day.
A modiﬁed SHIRPA screen was used to assess general health,
autonomic functions, reﬂexes, posture, movement, and sponta-
neous behavior. Consistent with prior observations12, we found
age-related changes on a subset of SHIRPA measures (presence of
tremor, gait abnormalities, tail elevation, reduced vocalization,
reduced, or absence of startle response) (Supplementary Table 6).
These did not appear to be prevented by EOD. We do note,
however, that larger sample sizes would be needed to be able to
detect effects on these types of measures.
Exploratory activity was examined in an open-ﬁeld assay, in
which we allowed mice to explore freely a novel environment for
a 20-min period. Consistent with previous observations12, 15,
these experiments showed overall reduced exploration in aged
mice compared to young animals, as indicated by reduced
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distance traveled measures and reduced numbers of rearings
(Fig. 2a, b). EOD increased exploratory activity in both young
mice on short-term treatment and aged mice on almost lifelong
treatment (Fig. 2a–d; full data set in Supplementary Table 7).
We examined motor coordination and balance using the
accelerating rotarod. These analyses showed the expected12, 15 age
effects with signiﬁcantly reduced latencies to fall in aged animals
(Fig. 2f). We observed a possible slight improvement of latencies
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Fig. 1 EOD extended lifespan and delayed lethal neoplastic disease but had limited effects on aging rate. a Schematic illustration of the experimental design.
b Estimated food intake per animal (number of cages at initiation AL: n= 18, EOD: n= 17). c Body weight (AL: n= 72 mice, EOD: n= 68 mice at initiation).
Statistical analyses for b and c were performed using a mixed effects model with DR as ﬁxed effect and cage and time as random effects. d Survival curves
(log-rank test; AL: n= 43 mice, EOD: n= 37 mice). e Maximum lifespan was calculated from the longest living 20% (t-test; AL: n= 9 mice, EOD: n= 8
mice). f Causes of natural deaths in AL (n= 29 mice) and EOD (n= 20 mice) animals. g Tumor burden in animals that died of natural causes (AL: n= 29
mice, EOD: n= 20 mice). h–j Summary of large-scale phenotyping analyses to study organismal aging in AL and EOD mice. h The Venn diagram provides
an overview regarding the total number of phenotypes assessed (n= 239), the number of aging traits (n= 116), and parameters modiﬁed by EOD (n= 89),
as well as overlaps of these sets of measures. Forty aging traits were ameliorated by EOD, of which 7 were prevented by EOD and 33 were modulated with
similar outcomes in young mice, treated for only 1 month, and in aged animals kept on almost lifelong EOD. Fourteen aging traits were exacerbated by EOD.
i Effect sizes (Cohen’s d) of age are plotted against effect sizes of EOD (in old mice) for all aging traits (black dots; n= 116), as well as for all traits
modulated by both age and dietary intervention (red dots; n= 53). In both cases, the data show an inverse correlation of the effects of age and DR. j Effect
sizes (Cohen’s d) of EOD in young mice are plotted against effect sizes of EOD in old mice for all traits modulated by diet (black dots; n= 88), as well as for
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Fig. 2 Neurological and ophthalmological phenotypes. a–j Assessment of neurological and behavioral phenotypes (two-way ANOVA; young + AL: n= 16,
young + EOD: n= 16, old + AL: n= 23, old + EOD: n= 23). Analysis of locomotor activity including a total distance moved, b number of rears, c total resting
time, d average speed, and e latency to enter the center as determined in an open-ﬁeld test. f Latencies to fall on an accelerating rotatod. g, h Muscle
strength measured by two-paw (forelimb) and four-paw grip strength tests. i, j Latencies to ﬁrst and second reaction in a hot-plate-based assessment of
nociceptive function. k Quantiﬁcation of mean lens density by Scheimpﬂug imaging (two-way ANOVA; young + AL: n= 7, young + EOD: n= 8, old + AL:
n= 7, old + EOD: n= 6). l Assessment of visual acuity using the virtual drum test (two-way ANOVA; young + AL: n= 7, young + EOD: n= 8, old + AL: n= 7,
old + EOD: n= 6). Analysis of m auditory brain stem responses (young + AL: n= 12, young + EOD: n= 12, old + AL: n= 10, old + EOD: n= 10), n acoustic
startle response and o pre-pulse inhibition (PPI). Statistical analyses for n and o were performed using a three-way ANOVA with the between-subjects
factors age (young vs. old), DR (AL vs. EOD), and the within-subjects factor sound intensity (Greenhouse-Geisser correction) (young + AL: n= 16, young +
EOD: n= 16, old + AL: n= 23, old + EOD: n= 23). AL ad libitum, EOD every-other-day feeding, a.u. arbitrary unit, n.r. no response. Data are shown as mean
± SEM. Full data sets of the open-ﬁeld test and Scheimpﬂug imaging are presented in Supplementary Tables 7 and 8
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Fig. 3 Cardiological analyses and assessment of bone structure. a–g Ventricular dimensions and functions were examined with transthoracic
echocardiography (two-way ANOVA; young + AL: n= 10, young + EOD: n= 9, old + AL: n= 11, old + EOD: n= 11). Dimensions of a interventricular septum
in diastole, b interventricular septum in systole, c left ventricle in diastole, and d left ventricular posterior wall in diastole were determined. e Mass of left
ventricle, f stroke volume, and g cardiac output were calculated. h–p ECGs were recorded from conscious mice (two-way ANOVA; young + AL: n= 10,
young + EOD: n= 9, old + AL: n= 11, old + EOD: n= 11). h HR, i RR interval, j PQ interval, k PR interval, l QRS interval, m QT interval, n ST interval, o QTc
interval, p QTc dispersion. q–s Bone architecture was examined using micro-CT of distal tibia (two-way ANOVA; young + AL: n= 16, young + EOD: n= 9,
old + AL: n= 17, old + EOD: n= 9). q Marrow area, r cortical thickness, s polar moment of inertia. AL ad libitum, EOD every-other-day feeding. Data are
shown as mean± SEM. Full data sets of echocardiography, electrocardiography, and micro-CT assessments are presented in Supplementary Tables 10–12
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00178-3 ARTICLE
NATURE COMMUNICATIONS |8:  155 |DOI: 10.1038/s41467-017-00178-3 |www.nature.com/naturecommunications 5
to fall in EOD-treated old mice compared to age-matched
controls but without reaching statistical signiﬁcance (Tukey
post hoc test following two-way ANOVA, old/AL vs. old/EOD: p
= 0.4146) (Fig. 2f). We also examined motor strength in EOD
mice and controls using two-paw and four-paw versions of a grip
strength test. These analyses revealed the expected12, 15 age-
related reductions in grip strength and suggested a small but
statistically insigniﬁcant improvement in EOD-treated old mice
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relative to AL-fed aged controls (Tukey post hoc tests following
two-way ANOVAs; forelimb grip strength, old/AL vs. old/EOD:
p= 0.4463, four-paw grip strength, old/AL vs. old/EOD:
p= 0.6789) (Fig. 2g, h).
We assessed nociceptive functions in EOD mice and controls
using a hot plate test. These studies showed the expected12
increases in reaction latencies in aged mice compared to young
animals, suggesting age-related alterations in nociceptive func-
tion. EOD did not attenuate these aging-associated behavioral
changes in the hot plate test but instead further increased reaction
latencies in aged mice (Fig. 2i, j).
EOD did not alter age-related increases in lens density. The
most common aging-associated pathology in the anterior part of
the eye is cataract formation16. We used Scheimpﬂug imaging to
measure abnormalities in the anterior segment of the eye,
including changes in lens density in young and old EOD and
control mice. These studies showed the expected12, 16 age-related
increase in mean lens density (Fig. 2k). EOD did not improve
aging-associated increases in mean lens density in any obvious
and measurable way (Fig. 2k; full data set in Supplementary
Table 8).
The posterior part of the eye was assessed using in vivo optical
coherence tomography, fundoscopy, and histological analyses,
demonstrating, consistent with previous observations12, normal
retinal thickness and apparently unaltered retinal vasculature in
aged mice (Supplementary Table 9).
Visual acuity was examined using the virtual drum test.
Consistent with results obtained from previous work12, 17,
performance of aged animals was worse compared to young
animals (Fig. 2l). Only one out of seven aged control mice was
able to complete this task, whereas performance was improved in
old EOD animals. EOD enhanced performance in both young
and aged cohorts, indicating age-independent effects on perfor-
mance in this visual acuity task (Fig. 2l).
Age-dependent hearing loss was not ameliorated by EOD.
Presbycusis is a common issue in elderly individuals and is
associated with a loss of hair cells and spiral ganglion sensory
neurons18. Age-dependent hearing loss also is a feature of C57BL/
6J mice, beginning between 12 and 15 months of age in the higher
frequencies and progressing to lower frequencies18. For a gross
assessment of age-dependent hearing loss in young and old
control and EOD mice, we subjected animals to the clickbox test,
in which the responsiveness of mice to a 20 kHz sound is
recorded. These experiments showed the expected12, 18 lack of
responding in the aged groups (Fig. 2m). Auditory brain stem
response measurements conﬁrmed the complete aging-associated
hearing loss and showed no EOD effects on stimulus intensity
thresholds (Fig. 2m). In summary, aged animals showed the
expected sensorineural hearing loss, which was unaffected by
EOD at that age. However, intermediate shift of onset or pro-
gression was not assessed.
We also assessed acoustic startle reactivity and pre-pulse
inhibition (PPI) in young and old EOD mice and controls. As
expected12, 19, aged animals showed reduced startle responses to a
range of different sound intensities (Fig. 2n). EOD decreased
responding independent of age and across several sound
intensities (Fig. 2n). PPI was largely absent in the aged groups
(Fig. 2o). EOD in young mice had no effect on PPI (Fig. 2o).
Together, these data are consistent with the clickbox data and
auditory brain stem response measurements mentioned above
and indicate that age-related hearing loss was not prevented by
EOD.
EOD reduced heart weight and cardiac dimensional measures.
Aging is associated with signiﬁcant changes in heart structure and
function20. To test for gross structural changes in the aged heart,
we measured heart dimensions via echocardiography and
obtained heart weights upon pathological assessment of the ani-
mals. Some dimensional measures showed expected12, 21, 22 age-
related increases that were either partially or fully restored by
EOD with similar effects in young and old mice (Fig. 3a–e; full
data set in Supplementary Table 10): thickness of interventricular
septal wall in diastole (IVSd), left ventricular end-diastolic
internal diameter (LVIDd), corrected left ventricular mass (LV
mass corr). Consistent with these echocardiography ﬁndings, we
observed reduced heart weights in EOD mice of both age groups
upon pathological assessment (Supplementary Fig. 1i). EOD also
altered a number of additional structural and functional echo-
cardiography measures, including fractional shortening (FS),
ejection fraction, and stroke volume (Fig. 3f and Supplementary
Tables 10 and 11). These EOD effects often appeared to be more
pronounced in the young group than in the aged set of animals.
In sum, EOD effects were consistent with a retardation of heart
growth (particularly evident in the young group) and conse-
quently reductions in heart dimensional measures described
above.
EOD did not modify age-related changes in bones and joints.
Progressive bone loss with age results in osteoporosis, reduced
bone strength, and fractures23. We measured cortical bone
architecture by micro-CT analyses of the distal tibia. Consistent
with previous reports24, 25, signiﬁcant age-dependent alterations
were detected in a subset of parameters (decreased cortical
thickness with increased marrow cavity area and polar moment of
inertia) (Fig. 3q–s; full data set in Supplementary Table 12). Age-
dependent changes in cortical bone architecture were not affected
by EOD. We also performed X-ray radiography of spine, ribs,
scapulae, clavicle, pelvis, femur, humerus, ulna, tibia, digits, joints,
jaws, teeth, ﬁbula, radius, ribs, and skull, conﬁrming no obvious
skeletal abnormalities in aged or EOD mice detectable at this level
of analysis.
Fig. 4 Energy metabolism and water turnover. a–l Indirect calorimetry was conducted over a period of 47 h, initiated at 7 a.m. (young + AL: n= 16, young +
EOD: n= 16, old + AL: n= 16, old + EOD: n= 16). The dark/light cycle was kept at 12:12 h (lights on 6 a.m. CET, lights off 6 p.m. CET). For mice assigned to
the EOD cohorts, food was removed after the ﬁrst 24 h. Water was supplied AL to all groups. Temporal pattern of a oxygen consumption, b carbon dioxide
production, c HP, d distance moved, e food intake, and f respiratory exchange rate are shown. g Oxygen consumption, h carbon dioxide production, i HP, j
food intake, and k water consumption per g body weight as well as l mean respiratory exchange rate were calculated. m TEWL was measured non-
invasively using a special Tewameter (young + AL: n= 15, young + EOD: n= 16, old + AL: n= 22, old + EOD: n= 23). Statistical analyses of a–f were
performed via three-way ANOVA with the between-subjects factors age (young vs. old), DR (AL vs. EOD) and the within-subjects factor time
(Greenhouse-Geisser correction) for feeding and fasting day, respectively. Statistics of g–m were calculated via two-way ANOVA with between-subjects
factors age (young vs. old) and DR (AL vs. EOD). AL ad libitum, EOD every-other-day feeding. Data in a–f are presented as mean. Data in g–m are shown as
mean± SEM. The full indirect calorimetry data set is presented in Supplementary Table 13
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Calorimetry revealed altered metabolic proﬁles in EOD mice.
Indirect calorimetry was conducted over a period of 47 h, such
that, in the EOD groups of mice, time windows with AL access to
food (24 h), as well as complete food restriction (23 h) were
covered experimentally. During the day with AL access to food,
all groups (i.e., young/old, AL/restricted) showed a typical
ultradian rhythm in energy expenditure and physical activity with
lower gas exchange during the day and an increase in the evening
triggered by the onset of the dark phase (Fig. 4a–d). On the food
restriction day, daytime energy expenditure did not differ con-
siderably between groups (Fig. 4c). EOD mice, however, tended to
show reduced oxygen consumption and carbon dioxide
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production rates during the second half of the night of the food
restriction day (Fig. 4a, b). Only two restricted mice (one young,
one aged) showed a metabolic suppression similar to torpor
typical for small rodents. Overall, levels of oxygen consumption,
carbon dioxide production, and heat release were, however, sig-
niﬁcantly increased in EOD mice when body weight differences
were accounted for (Fig. 4g–i; full data set in Supplementary
Table 13).
The availability of food as well as the age of the mice had effects
on metabolic fuel utilization (Fig. 4e, f, l). Consistent with prior
ﬁndings12, 26, aged control mice showed signiﬁcantly reduced
average respiratory exchange ratios (RER) compared to young
control animals (Fig. 4f, l), indicating a proportional substrate
preference toward lipid oxidation in aged mice. The metabolic
proﬁle of young control mice was dominated by low RER
(indicative for lipid oxidation) during daytime and shifted to
higher RER (reﬂective for carbohydrate utilization) in the evening
(Fig. 4f). Aged control mice, in contrast, showed low RER values
with little variability throughout the entire period of assessment
(Fig. 4f). Young EOD mice showed high RER values during the
feeding day and low RER values during the starvation day
(Fig. 4f). The temporal RER proﬁle in old EOD mice showed
similarities with that in young EOD mice but was shifted by ~12
h, such that RER began to rise at ~12 h after onset of food
availability and remained high for ~12 h during the starvation day
(Fig. 4f). The RER proﬁles in the young groups described above
were consistent with the observation that food intake occurred
primarily during the dark phase in controls, while young EOD
mice also engaged in food consumption during the light phase
(Fig. 4e). This pattern appeared to be less pronounced in aged
animals on almost lifelong EOD (Fig. 4e), possibly reﬂecting
adaptation to this long-term feeding regimen.
Increased water turnover in EOD mice. Transepidermal water
loss (TEWL) measurements are useful as an initial approach for
identifying skin damage (e.g., associated with pathological con-
ditions, such as eczema, or caused by chemical or physical
insults), whereby TEWL rates increase proportionally to the level
of damage. We subjected aged and young EOD and control mice
to TEWL measurements using a Tewameter placed on the skin.
Our analyses showed no obvious effect of aging but an overall
increase of TEWL in EOD mice relative to AL-fed controls
(Fig. 4m). Consistent with increased rates of water loss in EOD
mice, measurements of water intake showed excessive water
consumption in these animals (Fig. 4k and Supplementary
Table 13). It remains to be determined in future studies whether
excessive water intake serves to compensate for water loss or
whether there is increased TEWL due to increased rates of water
uptake. One likely scenario may be that excessive food intake
during the feeding day is associated with increased water intake
and consequently increased water loss in EOD mice.
Altered body composition in EOD mice. We examined body
composition (total fat, lean mass) in young and old EOD, as well
as AL-fed animals using time domain nuclear magnetic resonance
(TD-NMR). Advanced age was associated with the expected12, 26
increase in proportional body fat mass (fat mass adjusted to body
weight), as well as decrease in relative lean mass. Body mass was
consistently decreased in EOD mice of both age cohorts. Of note,
body composition was altered in EOD mice with a slight increase
in proportional fat mass and a corresponding decrease in relative
lean mass (Supplementary Fig. 1a–c), which likely reﬂects an
adaptive response to the intermittent availability of food.
EOD reduced leukocyte counts and increased hematocrit.
Aging in C57BL/6J mice is known to be associated with an altered
cellular composition of the peripheral blood12, 27, 28. Therefore,
we included in our analysis a basic hematological assessment of
young and old EOD mice and controls. Our observations, out-
lined below, are consistent with known aging effects on blood cell
counts (Fig. 5; full data set in Supplementary Table 14)12, 27, 28.
Red blood cell counts (RBC) were decreased in aged mice
(Fig. 5a). Consistent with the RBC results, hemoglobin con-
centrations and hematocrit (HCT) were reduced in aged mice
(Fig. 5b, c). RBC distribution width (RDW) values were increased
in aged animals (Fig. 5e), indicating a higher degree of anisocy-
tosis. Although EOD left RBC unaffected, it caused an overall
increase in hemoglobin concentrations and HCT across age
groups (Fig. 5b, c), accompanied by an increase in mean cor-
puscular volume (MCV) and mean corpuscular hemoglobin
content (Supplementary Table 14). In addition, EOD reduced
RDW values in both the young and aged group of mice (Fig. 5e).
Overall, similar treatment outcomes in young and aged animals
suggested that these changes in hematological parameters were
related to age-independent effects associated with EOD. Our
studies also revealed elevated platelets counts in aged animals
(Fig. 5f). Though no measurable EOD effect on platelet counts
and plateletcrit (PCT) was detected, platelet volume, platelet
distribution width (PDW), and platelet large cell ratio were
reduced in EOD animals regardless of age (Fig. 5f–j). Leukocyte
counts were reduced by EOD across age groups (Supplementary
Table 14).
EOD attenuated a subset of aging-associated immune changes.
Age-related immune dysfunction leads to an increased prevalence
of infections and autoimmune disease in the elderly and may also
contribute to the increased cancer risk in aged individuals29, 30.
Immune aging phenotypes affect the lymphocyte, as well as
myeloid compartment in the peripheral blood and include
decreased numbers of T and B lymphocytes, decreased natural
killer (NK) cell frequencies, as well as increased frequencies of
monocytes and neutrophil granulocytes29, 30.
To test for alterations with regard to these immune
phenotypes, we performed ten-color polychromatic ﬂow cyto-
metry and quantiﬁed a subset of immune cell populations in
young and old EOD and AL-fed mice. Consistent with published
data12, 31–34, these experiments showed aging-associated
decreases in T cells, B2 cells, as well as NK cells (Fig. 5k, m, p;
Fig. 5 Hematological and immunological analyses. a–j Number and size of the different blood cell types were determined using a hematology analyzer
(two-way ANOVA; young + AL: n= 16, young + EOD: n= 16, old + AL: n= 20, old + EOD: n= 22). a RBC count, b hemoglobin concentration, c HCT,
d MCHC, e RDW, f platelet count, g platelet volume, h PDW, i large cell ratio of platelets (>12 ﬂ), and j PCT. k–w Peripheral blood leukocytes were
analyzed using a ten-color ﬂow cytometer (two-way ANOVA; young + AL: n= 16, young + EOD: n= 16, old + AL: n= 20, old + EOD: n= 22). Only CD45-
positive cells were included in the analysis. k T cells (CD3+CD5+), l Ly6C+ T cells, m B2 cells (CD5−CD19+B220+), n CD11b+ B cells (CD19+B220+), o Ly6C
+ B cells (CD19+B220+), p natural killer (NK) cells (CD3−CD5−NKp46+ and/or NK1.1+), q CD11b+ NK cells, r CD11c+ NK cells, s NKT cells (CD3+CD5
+NKp46+ and/or NK1.1+), t granulocytes (CD11b+Ly6G+), u Ly6C+ monocytes (CD11b+), v Ly6C− monocytes (CD11b+), w non-speciﬁc cells, x plasma
concentration of IgE immunoglobulins. AL ad libitum, EOD every-other-day feeding. Data are shown as mean± SEM. Full data sets of hematological and
immunological analyses are presented in Supplementary Tables 14 and 15
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full data set in Supplementary Table 15). EOD increased T-cell
frequencies in both the young mice on short-term EOD and aged
mice chronically subjected to EOD during aging, indicating age-
and exposure-time-independent effects of EOD on this measure
(Fig. 5k). Aging is known to be associated with an increase in the
proportion of T cells expressing memory markers, such as CD44
and/or Ly6C12, 35. The age-dependent increase of Ly6C+ T cells,
observed in the present study, remained unaffected by EOD
(Fig. 5l). Neither expected age-related decreases of B2 cells33 nor
increases of CD11b+ and Ly6C+ B-cell frequencies were
prevented by EOD (Fig. 5m–o). Furthermore, EOD had no
measureable effect on the expected12, 32 aging-associated decline
in NK cell frequencies (Fig. 5p). However, NK cell subpopulations
were modiﬁed by EOD, such that levels of CD11b+ and CD11c+
NK cells were reduced (Fig. 5q, r) and the percentage of Ly6C+
NK cells was elevated (Supplementary Table 15). Interestingly,
age-dependent decreases of NKT cells were fully recovered by
EOD (Fig. 5s). With regard to the myeloid compartment, our
experiments conﬁrmed12, 27 age-related increase in neutrophil
granulocytes, as well as monocytes in the peripheral blood
(Fig. 5t–v). EOD did not appear to attenuate the aging-associated
increases with regard to these myeloid cell populations in the
peripheral blood (Fig. 5t–v).
EOD did not alter aging-associated changes in plasma IgE. We
performed ELISAs to measure plasma IgE immunoglobulin levels,
which are expected to increase with advanced age12. Our studies
conﬁrmed increased plasma IgE concentrations in aged mice
(Fig. 5x). EOD did not ameliorate these aging-associated eleva-
tions in plasma IgE concentrations (Fig. 5x).
EOD and age effects on clinical chemistry measures. In line
with previous observations12, 28, we observed a number of clinical
chemistry measures inﬂuenced by age (plasma taken from ani-
mals in the fed state). We observed aging-associated changes in
plasma concentrations of sodium (increased in old mice),
potassium (increased in old mice), urea (increased in old mice),
glucose (decreased in old mice), albumin (decreased in old mice),
unsaturated iron-binding capacity (increased in old mice),
activity of alkaline phosphatase (increased in old mice), and
lactate dehydrogenase activity (increased in old mice) (Fig. 6a–h;
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full data set in Supplementary Table 16). There appeared to be
changes with regard to plasma concentrations of fructosamine
(decreased in old mice) and α-amylase activity (increased in old
mice) but without reaching statistical signiﬁcance (Supplementary
Table 16). EOD had no measurable antagonistic effect on several
of these aging-associated changes, including those regarding
plasma concentrations of sodium, potassium, glucose, albumin,
and fructosamine. EOD did, however, appear to ameliorate aging-
associated changes in plasma concentrations of urea, unsaturated
iron-binding capacity, alkaline phosphatase activity, lactate
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dehydrogenase activity, and α-amylase activity (Fig. 6c, f–h;
Supplementary Table 16). Recovery of plasma urea concentration
was the only parameter with EOD effects speciﬁcally in the aged
cohort subjected to almost lifelong treatment, whereas all other
parameters were inﬂuenced by EOD in similar ways in young
mice on short-term EOD and aged mice on almost lifelong EOD.
We also noted additional main effects of EOD: EOD mice
showed decreased plasma concentrations of calcium, phosphate,
total protein, and triglycerides (Supplementary Table 16). Stron-
gest effects were seen, unexpectedly, for parameters associated
with iron metabolism: While total iron-binding capacity was only
slightly decreased in EOD animals, we found a strong decrease of
unsaturated iron-binding capacity and a corresponding increase
of plasma iron levels in EOD mice (Fig. 6f and Supplementary
Table 16). This difference was stronger in the young group than
in aged animals.
A subset of parameters was measured in plasma isolated after a
6 h food withdrawal on a regular fasting day (full data set in
Supplementary Table 17). After fasting, non-esteriﬁed fatty acids
showed a signiﬁcant main effect of age (decreased in old mice),
without apparent correction by EOD (Fig. 6i). Several parameters,
such as plasma levels of cholesterol, high-density lipoprotein
cholesterol, triglycerides, and glucose, were decreased in EOD
mice in an age-independent fashion (Supplementary Table 17).
Glucose homeostasis in EOD mice. To assess possible age- or
diet-related changes in glucose tolerance, we performed an
intraperitoneal glucose tolerance test (IpGTT) in young and old
EOD and control animals (this was performed after 6 h of fasting
on a day without access to food). We observed a signiﬁcant main
effect of EOD on basal glucose levels with levels reduced in EOD
mice independent of age (Fig. 6k). Glucose tolerance was sig-
niﬁcantly improved in EOD mice of both age groups (Fig. 6k).
Notably, inter-individual variance of glucose tolerance was much
higher in aged control animals than in aged EOD mice. We did
not observe signiﬁcant main effects of age with regard to basal
glucose levels and glucose tolerance.
We also measured insulin levels in young and old EOD and
control animals (after 6 h of fasting on a day without food access).
Consistent with published work36, aged AL-fed mice showed
elevated insulin levels compared to young controls (Tukey post
hoc test following two-way ANOVA, old/AL vs. young/AL:
p= 0.0004) (Fig. 6j). These analyses also revealed clear decreases
in insulin levels in aged EOD mice (Tukey post hoc test following
two-way ANOVA, old/AL vs. old/EOD: p= 0.0005) (Fig. 6j),
likely reﬂecting increased insulin sensitivity in these animals.
EOD ameliorated some aging-associated histological changes.
We used histopathology to assess young and old EOD and con-
trol animals for the presence of eosinophilic thalamic inclusions,
cytoplasmic inclusions in thalamic neurons that progressively
develop during aging in mice37 and men38. Consistent with
published data37, eosinophilic thalamic inclusions were present in
most of the AL-fed aged mice (Fig. 7a). These inclusions were
rarely found in the old EOD animals (Fig. 7a). Eosinophilic
thalamic inclusions were not present in young mice, either on
EOD or AL access to food.
Aging-related changes in the thyroid gland include increasing
follicle size and decreasing colloid resorption (reﬂecting decreas-
ing thyroid activity in the aged animal)39. We performed
morphometric histopathological analyses to assess follicle size
distribution in the thyroid gland of young and old EOD and
control animals. These studies revealed the expected12, 39 aging-
associated increase in thyroid follicle size (Fig. 7b). EOD reduced
thyroid follicle size in both young mice on short-term EOD and
aged mice subjected to almost lifelong EOD (Fig. 7b).
Aging-related histopathological alterations in the adrenal
glands include adrenal adenomas, subcapsular cell hyperplasias,
and lipofuscin depositions40. We employed morphometric
histopathology to assess quantitatively the presence of lipofuscin
deposits in the adrenal glands of young and old EOD mice and
controls. Statistical analyses revealed an overall decrease in
adrenal gland lipofuscin deposits in EOD mice (Fig. 7c).
Age-associated changes in the liver include fat accumulation,
ﬁbrotic changes, inﬂammatory/immune alterations, and can-
cers12, 41. We performed a histopathological assessment of liver-
associated aging phenotypes in EOD mice and age-matched
controls. AL-fed aged animals displayed microgranulomas (some
with councilman bodies) and visible Kupffer cells (usually a sign
for activation) (Fig. 7d). The number of hepatic microgranulomas
was decreased in aged EOD mice (Tukey post hoc test following
two-way ANOVA, old/AL vs. old/EOD: p= 0.0004) (Fig. 7d).
Aging-associated pathological changes in the kidney include
glomerulosclerosis, loss of renal mass, and hyalinization of
afferent arterioles12, 42–44. Obvious glomerulosclerotic changes
were found in only one aged control animal. Quantitative
assessment of urinary casts revealed that these features were
largely absent in young mice but were prominent in aged AL
animals and reduced in aged EOD mice (Tukey post hoc test
following two-way ANOVA, old/AL vs. old/EOD: p< 0.0001)
(Fig. 7e). Hyaline vascular changes were detected to some extent
in both young and old mice, though these alterations were more
pronounced in aged animals. EOD decreased hyaline vascular
changes across age groups (Fig. 7f). With advanced age, tubular
epithelial cells become atrophic, which is associated with an
increase in tubular luminal space42. We used morphometric
histopathology to quantify tubular luminal space on kidney
sections. These analyses revealed a signiﬁcant main effect of age
on this measure, which was attenuated by EOD (Fig. 7g).
EOD had limited effects on testicular atrophy and BALT.
Histopathological analyses of the male reproductive tract revealed
the expected12, 45 signs of testicular atrophy in aged mice. Con-
sistent with age-dependent loss of testis weight (Supplementary
Fig. 1n), seminiferous epithelium/lumen ratio of seminiferous
tubules was signiﬁcantly decreased in both old animal cohorts
regardless of diet (Fig. 7h).
Fig. 7 Histopathology. Representative images of sections derived from the a brain (scale bar= 20 µm), b thyroid gland (scale bar= 500 µm), c adrenal
gland (scale bar= 500 µm), d liver (scale bar= 100 µm), e–g kidney (in e, f: scale bar= 200 µm; in g: scale bar= 100 µm), h testis (scale bar= 500 µm),
and i lung (scale bar= 200 µm) are shown on the left. Quantiﬁcation of a proportion of animals bearing eosinophilic thalamic inclusions (indicated by
arrows), b median follicle size of the thyroid gland, c relative surface area covered by lipofuscin deposits within the adrenal gland, d number of hepatic
microgranulomas (indicated by arrows), e number of urinary casts in the kidney (indicated by arrows), f number of hyaline changes in renal arterioles
(indicated by arrows), g the relative surface area on renal sections covered by tubular luminal space, h ratio of testicular seminiferous epithelium/lumen in
seminiferous tubules, and i coverage of broncheoli-associated lymphoid tissues (BALT) in the lung (indicated by arrows) are presented in panels on the
right. Data in b are shown as median± SEM and data in c–i are presented as mean± SEM. Statistical analyses was performed using Fisher’s exact test for a
or two-way ANOVA for b–i (young + AL: n= 16, young + EOD: n= 16, old + AL: n= 19, old + EOD: n= 20). AL ad libitum, EOD every-other-day feeding
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00178-3
12 NATURE COMMUNICATIONS | 8:  155 |DOI: 10.1038/s41467-017-00178-3 |www.nature.com/naturecommunications
Aging is associated with the accumulation of lymphatic cells in
various organs12, 14, consistent with a proinﬂammatory state in
aged individuals. We performed histopathological assessments to
determine if aging had an effect on the presence of lymphatic
tissue in the lung (broncheoli-associated lymphatic tissue, BALT)
and, if so, whether EOD had an effect on this aging trait. BALT
was present to various degrees in some of the aged mice
irrespective of diet group (Fig. 7i), but not in young animals. EOD
did not appear to inhibit the accumulation of BALT in the lung
during aging.
RNA-seq did not show EOD effects on transcriptional changes.
We employed RNA-seq analyses to determine whether EOD-
modiﬁed transcriptional changes associated with aging (young/
AL: n= 4 mice; young/EOD: n= 3 mice; old/AL: n= 4 mice; old/
EOD: n= 4 mice; starting material: whole brain). Differential
expression analyses identiﬁed 196 genes differentially expressed
(FDR< 0.1) in old vs. young brains (Supplementary Data 1). Top
differentially expressed genes included various immune regulators
and effectors, such as Lyz2, Il33, and components of the com-
plement system (e.g., C4b, C3, and C1qa). Pathway analyses
comparing these 196 differentially expressed genes to the entire
set of genes revealed many changes consistent with proin-
ﬂammatory alterations in the aged brain (Supplementary Data 2).
We did not detect genes differentially expressed as a function of
diet (EOD vs. AL; FDR< 0.1) or with a signiﬁcant (FDR< 0.1)
interaction between the factors age and diet.
Limited EOD effects on aging. Among the 239 parameters tes-
ted, we detected 116 aging phenotypes (Fig. 1h). Surprisingly, in
only seven cases of those, did we obtain evidence for a prevention
of aging (Supplementary Table 2); examples are the prevention of
eosinophilic thalamic inclusions in brain and urinary casts in the
kidney (Fig. 7a, e). In 33 out of the 116 aging phenotypes, we
observed similar EOD effects on age-sensitive parameters in
young mice on short-term treatment and aged mice on almost
lifelong treatment (Supplementary Table 3). Examples of traits
falling in this category are aging-associated alteration in
exploratory locomotor activity, visual acuity, HCT, cardiac
dimensional measures, thyroid follicle size, T cell, and CD11c+
NK cell frequencies (Figs. 2, 3, 5, and 7). The majority of the
aging traits (76 out of the 116 parameters) examined in the
present study was not measurably improved by EOD (Supple-
mentary Table 4), including aging-associated changes in the
optical density of the lens, a range of neurobehavioral functions,
platelet counts, plasma immunoglobulin concentrations, and a
number of clinical chemistry measures (e.g., levels of plasma
sodium, potassium, or albumin) (Figs. 2, 5, and 6). Some age-
sensitive parameters (14 parameters; Supplementary Table 4),
such as decreased thickness of cortical bone and decreased
responsiveness upon assessment of auditory function, were more
pronounced in EOD mice than age-matched controls (Figs. 2 and 3).
In order to further understand the overall relationship of
aging and EOD effects in young and old mice, we performed
correlation analyses comparing the effect sizes of age and
EOD on the parameters included in the present study.
Comparison of effect sizes revealed an inverse correlation of
aging effects and EOD effects (Fig. 1i). EOD effect sizes in young
mice were tightly correlated with EOD effect sizes in aged mice
(Fig. 1j). This was also the case when the analysis was restricted to
aging traits ameliorated by EOD (Fig. 1j), indicating that EOD
had overall similar effects in aged mice subjected to almost
lifelong EOD and in young mice subjected to a short-term
treatment.
Discussion
Here we report on a large-scale assessment of DR effects,
employing an EOD regimen, on aging and lifespan in male
C57BL/6J mice. Consistent with previous EOD experiments8, 9, as
well as studies using other DR regimens, such as chronic CR4–7,
we observed an extension of median, as well as maximal lifespan
in animals subjected to EOD. Murine lifespan extension under
DR could in principle be due to isolated effects on speciﬁc life-
limiting pathologies, in particular cancers, or could alternatively
be caused by cancer suppression accompanied by broader anti-
aging effects in mice. We show that longevity in male C57BL/6J
mice subjected to EOD is associated with a delayed onset of lethal
neoplastic disorders that typically limit natural lifespan in many
mouse strains6, 14. Surprisingly, our large-scale analysis of >200
phenotypes across >20 tissues revealed only limited evidence for
an EOD-induced delay of aging in mice.
DR regimens commonly used in rodents are EOD (employed
in the present study) and CR. One of the important differences
between these two protocols is the net calorie intake. Daily food
supply of animals assigned to chronic CR is usually cut down to
60% of the amount consumed AL by age-matched controls
(equivalent with 40% restriction). Chronic CR results in lifespan
extension and pronounced growth retardation such that body
weight (−42% in rat, −35% in mouse), fat mass (−70% in rat), and
many organs weights (heart: −29% in rat; liver: −34% in rat, −31%
in mouse; kidney: −33% in rat, −10% in mouse; spleen: −50% in
rat, −66% in mouse; prostate: −25% in rat) are overall decreased
in adulthood6, 7. Exceptions are sizes of brain and testis, which
remain unaffected by chronic CR7.
In contrast, animals subjected to EOD quickly adjust feeding to
times of food availability and, therefore, show more modest
reductions in net calorie intake compared to CR. In line with the
CR ﬁndings mentioned above, EOD had strongest effects on
organ weight with regard to the spleen (−31% in young, −56% in
old). However, body length, fat mass, and the weights of most
organs were affected more modestly by EOD. Thus, when com-
pared to CR, EOD avoids partially the CR-associated growth
retardation, while still affording the beneﬁt of lifespan extension
and other health beneﬁts, such as improved insulin sensitivity and
hippocampal neuroprotection against excitotoxic injury3, 9.
The main causes of death in many mouse strains are neoplastic
pathologies6, 14. Therefore, it is likely that a generally important
aspect of lifespan-extending interventions in mice is the sup-
pression of cancer development in the context of natural aging46.
CR is known for its strong potential to suppress neoplasia4, 5, 47.
EOD has been shown to exert protection in various tumor-prone
rodent models48, 49. We here show that EOD reduces tumor
burden and delays lethal neoplastic disease during natural aging
in C57BL/6J mice. These considerations emphasize the need for
studies complementing lifespan analyses with detailed analyses of
treatment effects on a broad range of aging markers in different
tissues and organs.
Prior EOD studies had examined restriction effects on a few
additional parameters besides lifespan. Consistent with our
observation of elevated spontaneous locomotor activity in EOD
mice (in an open-ﬁeld assay), previous experiments in rats had
found increased levels of voluntary wheel running under EOD
restriction50. EOD exerted cardioprotective effects in rodent
ischemia models and, in line with the observations in the present
study, inﬂuenced a number of cardiac dimensional measures
consistent with a retardation of heart growth in restricted ani-
mals51. We also conﬁrmed prior results regarding expected
reductions of plasma glucose, triglyceride, and insulin con-
centrations in rodents subjected to EOD52.
Under conditions of food shortage, nocturnal rodents, such as
mice, are known to shift their activity pattern to also cover parts
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of the light phase53, 54; this could represent an adaptive response
that increases the chance to acquire food that is available only
during restricted temporal windows53. Accordingly, altered cir-
cadian activity patterns have to be taken into account as potential
confounds when considering outcomes of DR studies, including
those employing EOD and CR54, 55. However, prior analyses,
using CR, showed that feeding time inﬂuenced circadian rhythms,
but did not affect CR-induced lifespan extension56–58. Moreover,
AL-fed mice subjected to weekly 12-h shifts of their light-dark
schedule during much of their lifetime did not show alterations in
life expectancy compared to controls57. These data support the
notion that DR effects on circadian rhythms are independent of
longevity effects. Additional studies are needed to clarify whether
DR-induced circadian alterations might interact with DR effects
on aging phenotypes other than age-related mortality.
Our metabolic proﬁling experiments indicated that longevity in
EOD mice was not associated with reduced, but rather slightly
increased rates of energy expenditure, as evidenced by body
weight-adjusted oxygen consumption, carbon dioxide emission,
and heat production (HP). On the basis of the circadian patterns
of food intake and RER values (though not necessarily overall
locomotor activity), our metabolic analyses also provided some
evidence for the expected alterations in circadian activity patterns
in EOD mice (see above), which were particularly evident in the
young cohort of animals. These changes were less clear in aged
mice on almost lifelong EOD, raising the possibility that DR-
associated shifts in circadian activity and associated metabolic
parameters may be transient in nature and return to more typical
nocturnal patterns with extended exposure to DR.
Our study had several limitations. The data were collected in
one speciﬁc mouse strain (i.e., C57BL/6J) and sex (i.e., male). We
focused our analyses on two speciﬁc age groups, including a
young cohort with DR beginning at 8 weeks of age and pheno-
typic analyses commencing at ~3 months of age, as well as an
aged cohort with DR commencing at 8 weeks of age and phe-
notyping starting at ca. 21 months of age. We did not examine
additional intermediate or older cohorts. Future studies including
such additional groups could deﬁne more detailed lifetime tra-
jectories of the different traits examined. Furthermore, we would
like to note that additional studies are needed to address whether
other methods of DR, such as CR, have broader effects with
regard to delaying natural aging.
Two important studies using rhesus macaques (Macaca
mulatta) were launched in the late 1980s to explore CR-driven
long-term survival and health outcomes in primates. The ﬁrst
study was initiated at the National Institute on Aging (NIA) in
1987, the latter started at the Wisconsin National Primate
Research Center (WNPRC) in 1989. While CR extended lifespan
in the WNPRC cohort, survival was not improved in the NIA
study59, 60. This discrepancy in survival outcomes might be
attributable to differences in study design, including feeding
protocols (e.g., control monkeys in the WNPRC study ate AL,
while controls in the NIA study received deﬁned daily food
portions)61. The incidence of speciﬁc age-related diseases
(including cancer and diabetes) was reduced by CR in both the
WNPRC and NIA study, showing that some of the expected
health beneﬁts are reproducible across studies. The impact of
EOD in non-human primates has not been investigated so far and
remains to be determined in future studies.
From a translational point of view, EOD or other forms of IF
are attractive because of the overall low degree of food limitation
associated with this form of DR11. The feasibility of applying IF to
humans has been validated in a number of short-term trials over
the past decade. Closely matching our ﬁndings in mice, IF
decreased body weight and modulated parameters associated with
insulin and fat metabolism after a few weeks of treatment62.
However, these studies focused on acute effects, included only a
limited set of measures and long-term health outcomes remain
unexplored. Thus, the current study provides a foundation for the
design of future long-term IF trials in humans.
In conclusion, our data indicate that EOD-induced lifespan
extension in male C57BL/6J mice is sufﬁciently explained by a
delay in lethal neoplastic disorders. Our large-scale assessment of
molecular, cellular, physiological, and histopathological pheno-
types in aging mice identiﬁed only a small proportion of aging
traits delayed by EOD, suggesting that lifespan extension was not
associated with a broad slowing of the aging process in EOD
mice.
Methods
Mice. For both, survival analysis as well as broad phenotyping of aging traits, male
C57BL/6J mice were obtained as one cohort from Charles River Laboratories and
were randomly assigned to the AL (AL = control) or every-other-day fasting
(EOD) regimen. EOD was initiated at 2 months of age. All animals received a
standard rodent chow (Altromin 1314) and were kept on their respective diet
regimen for the entirety of the study (see below for more details regarding EOD).
Body weight was measured weekly over the entire course of the study. Food
intake was estimated monthly by averaging food consumption on 4 consecutive
days covering two fasting and two feeding days. For analyses of age- and EOD-
sensitive traits, we analyzed a large set of molecular, cellular, physiological, and
histopathological parameters in young and old EOD and control mice (age and
number of animals at initiation of analyses: 21 months old control, n= 24 mice;
21 months old EOD, n= 24 mice; 3 months young control, n = 16 mice; 3 months
young EOD, n= 16 mice). The following analyses were performed (in the order
mentioned)63: open ﬁeld (week 1), modiﬁed SHIRPA (week 1), grip strength (week 1),
rotarod (week 2), acoustic startle response, and PPI (week 2), hot plate test (week 4),
TEWL test (week 4), indirect calorimetry (week 5), NMR-based body composition
analysis (week 6), glucose tolerance test (week 7), awake electrocardiography, and
echocardiography (week 8), Scheimpﬂug imaging (week 9), optical coherence
tomography (week 9), laser interference biometry (week 9), virtual drum vision test
(week 9), clinical chemistry (week 10), hematology (week 10), FACS analysis of
peripheral blood leukocytes (week 10), Bioplex ELISA (Ig concentrations) (week 10),
auditory brain stem response (week 11), X-ray/bone densitometry (week 11), and
pathology (week 13). If not stated otherwise, we commenced with data collection in
the morning after a feeding day to avoid artiﬁcial effects driven by hunger. Mice (in
their home cages) were habituated to the test room for a period of 15min prior to
commencement of analyses for most experimental procedures (unless stated
otherwise). In all cases, the experimenter was blinded to the animal group
assignments.
Mice were housed under speciﬁc pathogen-free conditions, i.e., they were free of
deﬁned murine pathogens according to FELASA guidelines. The animals were
housed in groups of four mice per cage at initiation of the study. Animals were kept
at constant temperature of 22 °C on a 12:12 h light/dark cycle. Mice received water
AL. Local and federal regulations regarding animal welfare were followed. The
present study was approved by “Landesamt für Natur, Umwelt und
Verbraucherschutz Nordrhein-Westfalen” (Recklinghausen, Germany), as well as
“Regierung von Oberbayern” (Munich, Germany).
EOD Regimen. We chose a DR regimen (i.e., EOD) previously shown to extend
lifespan in mice9 and compatible with group housing the animals. Unlike other DR
paradigms (such as restriction of calorie intake to 60% of what animals would eat
AL), the feeding situation in the EOD paradigm is not associated with competition
for food (because food is available in excess during the feeding day) and therefore
does not require single housing of the animals.
Animals fed AL were granted unlimited access to food anytime. EOD was
conducted according to a published protocol allowing free access to food for 24 h
alternated by food deprivation for 24 h (also referred to as EOD)9. Food was
provided to the EOD cohorts at 9 am and withdrawn at 9 a.m. on the next morning
as described previously9. EOD was initiated at 2 months of age, corresponding to
the age of EOD onset associated with the largest effect size on lifespan in a previous
study on male C57BL/6J mice9. All animals received a standard rodent chow
(Altromin 1314; closely matching the composition of the rodent chow used in a
previous EOD longevity study on male C57BL/6J mice9) and were kept on their
respective diet regimen for the entirety of the study. The Altromin 1314 chow came
in solid pellets. Careful pilot analyses showed that mice did not crumble these
pellets. Accordingly, removing the pellets on the restriction days was sufﬁcient to
fully deprive the animals of food (no cage change required).
Open-ﬁeld. For the open-ﬁeld test, an apparatus (ActiMot, TSE) consisting of a
transparent and infrared light-permeable acrylic test box (internal measurements:
45.5 cm × 45.5 cm × 39.5 cm), equipped with two pairs of light beam strips, was
used. The center of the test arena was illuminated with about 200 lux and the
corners were enlightened by ~150 lux. Animals were transported to an area directly
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adjacent to the testing room 30 min prior to open-ﬁeld analyses. The 20-min open-
ﬁeld test itself was then started right away given that the novelty aspect of the
environment is a crucial component of the test. Parameters analyzed were: total
distance traveled, number of rears, total resting time, average speed, distance tra-
veled in periphery, speed in periphery, resting time in periphery, permanence in
periphery, distance traveled in center zone, time spent in center zone, speed in
center zone, resting time in center zone, permanence in center zone, latency to
enter the center zone, and number of center zone entries.
Acoustic startle response and PPI. Animals were transported to an area directly
adjacent to the testing room 30min prior to behavioral analyses. Next, we
employed a 5-min acclimation period to the test compartment (i.e., a mouse
restrainer), before the actual testing began. The PPI protocol was based on the
Eumorphia protocol. In brief, PPI was assessed using a startle apparatus set-up
(Med Associates), including four identical sound-attenuating cubicles. Background
noise was 65 dB, and startle pulses were bursts of white noise (40 ms). A session
was initiated with a 5-min acclimation period followed by ﬁve presentations of
leader startle pulses (110 dB) that were excluded from statistical analysis. Trial
types for the PPI included four different pre-pulse intensities (67, 69, 73, and 81
dB); each pre-pulse preceded the startle pulse (110 dB) by a 50 ms inter-stimulus
interval. Each trial type was presented 10 times in random order, organized in 10
blocks, each trial type occurring once per block. Inter-trial intervals varied from
20–30 s.
Modiﬁed SHIRPA. The modiﬁed SHIRPA screen was proposed as a rapid, com-
prehensive, and semi-quantitative screening method for qualitative analysis of
abnormal phenotypes in mouse strains64. We examined the mice using 17 test
parameters to detect phenotypic differences between dietary restricted and control
aged mice, as well as young controls. Each test parameter contributes to an overall
assessment of muscle, lower motor neuron, spinocerebellar, sensory and autonomic
function and is scored qualitatively following a deﬁned rating scale. Assessment of
each animal began with the observation of undisturbed behavior in a glass cylinder
(11 cm in diameter). The mice were then transferred to an arena consisting of a
clear Perspex box (420 mm × 260 mm × 180 mm) in which a Perspex sheet on the
ﬂoor is marked with 15 squares. Locomotor activity and motor behavior within this
area was observed. This was followed by a sequence of manipulations testing
reﬂexes. Throughout the entire procedure, abnormal behavior, biting, defecation,
and vocalization were recorded. Between testing of each mouse, fecal pellets and
urination were removed from the viewing jar and arena. The following functions
were evaluated in the context of the modiﬁed SHIRPA screen: muscle/lower motor
neuron function (body position, gait, tail elevation, defecation, and urination),
spinocerebellar function (body position, gait, tail elevation, and limp grasping),
sensory function (transfer arousal, touch escape, gait, pinna reﬂex, and trunk curl),
autonomic function (defecation and urination), neurological reﬂexes (contact
righting reﬂex and pinna reﬂex), general appearance (body weight, body position,
transfer arousal, touch escape, vocalization, biting, spontaneous activity, locomotor
activity, and abnormal behavior).
Grip strength. A grip strength meter system (Bioseb) was used to determine grip
strength of the mice. The task exploits the tendency of the mice to grasp a hor-
izontal metal grid while being pulled at the tail. During the set-up for the trial, the
mice grasped a special adjustable grid mounted on a force sensor. Mice were then
allowed to hold on to the grid with either two or four paws. Three trials over the
course of 1 min were conducted for each mouse. Mean values were used to
represent the grip strength of a mouse.
Rotarod. This task was carried out to determine balance, motor coordination, and
motor learning abilities on an accelerating rotarod (Bioseb). After the mice had
been placed on the test apparatus, rod rotations were continuously accelerated
from 4 to 40 rpm within the 5-min trial period. Trials ended when animals fell of
the rod, showed passive cycling or when 5 min expired, whichever came ﬁrst. For
each animal, three trials with inter-trial intervals of 15 min were performed. Data
are presented as the average of the three trials.
Auditory brain stem response. The auditory brain stem response test was per-
formed to assess hearing sensitivity in a non-invasive manner. Anesthetized mice
(ketamine/xylazine-based anesthesia) were transferred onto a heating blanket in
the acoustic chamber, followed by the positioning of three subcutaneous needle
electrodes. For threshold determination, we used clicks (0.01 ms duration) or tone
pips (6, 12, 18, 24, and 30 kHz of 5 ms duration, 1 ms rise/fall time) over a range of
intensity levels (from 5 to 85 dB SPL in 5 dB steps). The sound intensity threshold
was determined manually based on the ﬁrst appearance of the characteristic
waveform.
Hot plate test. The hot plate test was performed as described elsewhere12. The
animals were placed on a pre-heated metal surface (52± 0.2 °C) which was sur-
rounded by a circular Plexiglas wall (20 cm high, 28 cm in diameter) in order to
curtail the animals’ locomotion (Hot plate system, TSE). Mice were removed from
the plate after one of three responses indicative of a painful sensation occurred:
hind paw licking, hind paw shake/ﬂutter or jumping. The latency was recorded to
the nearest 0.1 s. The maximum testing duration was limited to 30 s to avoid tissue
injury.
Indirect calorimetry. Metabolic assessments were performed at room temperature
(23 °C) with a 12:12 h light/dark cycle in the room (lights on 6 a.m. CET, lights off
6 p.m. CET) for 2 consecutive days. The indirect calorimetry trial was conducted in
home cages equipped with food hoppers and water bottles. Mice were placed
individually into these respirometry cages for about 2 h before the actual recordings
were started. We carefully monitored that mice successfully used food hoppers and
water bottles during this habituation period and also throughout the consecutive
47 h. AL animals were granted free access to food and water, whereas the EOD
cohorts were only fed during the ﬁrst 24 h. Wood shavings and paper tissue was
provided as bedding material. Metabolic cages were set up in a ventilated cabinet
continuously supplied with fresh air. Variations in O2 and CO2 levels were
recorded by high precision CO2 and O2 sensors in each individual cage. Combined
with parallel airﬂow measurements, this enabled calculation of oxygen consump-
tion (expressed as ml O2/h/animal) over a given time period. The system also
monitored CO2 production, and, hence, it was possible to determine the RER and
heat production (HP). The RER was calculated as the ratio VCO2/VO2. HP was
calculated from VO2 and RER using the formula: HP (mW) = (4.44 + 1.43 ×
RER) × VO2 (ml/h). In addition, body mass was recorded before and after gas
exchange measurements. Cumulative food intake and water consumption were
monitored continuously. Physical activity (distance traveled, number of rearings)
was measured using infrared light beam frames set-up around the cages.
Body composition analysis. Body composition (lean tissue, body fat) was deter-
mined using a body composition analyzer (Bruker MiniSpec) based on TD-NMR.
Echocardiography. Transthoracic echocardiography was performed using a Vevo
2100 Imaging System (Visual Sonics) with a 30MHz probe to assess left ventricular
function. Examinations were performed on conscious mice to avoid effects of
anesthesia on cardiac function. Left ventricular parasternal short- and long-axis
views were obtained in B-mode imaging and left ventricular parasternal short-axis
views were obtained in M-mode imaging at the papillary muscle level. According to
the American Society of Echocardiography leading edge method65, LVIDd, left
ventricular end-systolic internal diameter (LVIDs), diastolic and systolic septal wall
thickness (IVSd and IVSs) and left ventricular diastolic and systolic posterior wall
thickness (LVPWd and LVPWs) were determined using short-axis M-mode images
derived from three consecutive beats. Fractional shortening (FS) was calculated as
FS% = ((LVIDd − LVIDs)/LVIDd) × 100. Ejection fraction (EF) was calculated as
EF%= 100 × ((LVvolD − LVvolS) LVvolD) with LVvol = ((7.0/(2.4 + LVID) ×
LVID3). The LV mass corr was calculated as LV mass corr= 0.8 (1.053 × ((LVIDd
+ LVPWd + IVSd)3 − LVIDd3)). The stroke volume (SV) was deﬁned as the
volume of blood ejected by one ventricle during one beat. SV of the left ventricle
was obtained by substracting end-systolic volume from end-diastolic volume. The
cardiac output was deﬁned as the volume of blood pumped by the heart per
minute. In addition, heart rate (HR) and respiratory rate were calculated by
measuring three systolic intervals and three respiratory intervals, respectively.
Electrocardiography. Electrocardiographs (ECGs) were recorded with the
ECGenie (Mouse Speciﬁcy) using conscious mice and were analyzed via e-Mouse
software (Mouse Speciﬁcs). Cardiac electrical activity was detected non-invasively
through the animals’ paws. For each animal, intervals and amplitudes were assessed
from continuous recordings of at least 15 ECG signals. Peak detections were used
to calculate the HR. HR variability (HRV) was calculated as the mean of the
differences between sequential heart beats. Interpretations of P, Q, R, S, and T for
each beat were plotted so that unﬁltered noise or motion artifacts were rejected.
Calculations of the mean of the ECG time intervals for each set of waveforms
followed. The corrected QT interval (QTc) was calculated by dividing the QT
interval by the square root of the preceding RR interval. QT dispersion was
measured as inter-lead variability of QT intervals. The QTc dispersion was cal-
culated as the rate QTc dispersion. The mean SR amplitude was calculated as the
mean amplitude of signal measured from the signal minimum line to peak of QRS.
The mean R amplitude was calculated as the mean amplitude of signal measured
from isoelectric line to peak of QRS. rMSSD was calculated as root mean square of
the successive differences of neighboring RR intervals. pNN50 was calculated as
percentage of adjacent RR intervals with differences larger than 50 ms. Parameters
analyzed were: HR, HRV, signal intensity, RR interval, PQ interval, PR interval,
QRS interval, QT interval, ST interval, QTc, QT dispersion, QTc dispersion, SR
amplitude, R amplitude, rMMSD, and pNN50.
Optical coherence tomography. The posterior part of the eye (fundus and retina)
was evaluated by a Spectralis OCT (Heidelberg Engineering) equipped with a 78
diopter double aspheric lens (Volk Optical) that was directly mounted to the outlet
of the apparatus. A contact lens with a focal length of 10 mm (Roland Consult) was
connected to the eye of the mouse with a drop of methylcellulose (Methocel 2%,
OmniVision). Prior of testing, 1% atropine was applied to dilate pupils. For
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measurements, anesthetized mice were placed on a platform in front of the
Spectralis OCT such that the eye was directly facing the lens of the recording unit.
Images were taken as described previously66. Retinal thickness was calculated with
the thickness proﬁle tool provided. Parameters evaluated were: pigmentation
(fundus), morphology of optic disk (fundus), number of main blood vessels
(fundus), retinal thickness, and morphology of retinal layers.
Scheimpﬂug imaging. The Pentacam digital camera system (Oculus) was used to
examine properties of cornea and lens. Mice were put on a platform such that the
center of the eye faced the vertical light slit (light source: LEDs, 475 nm). Assisted
by the software, optimal focus was obtained by distance adjustments between eye
and camera67. Lens densities (minimum, mean, maximum) were assessed quan-
titatively, whereas the morphologies of cornea and lens were evaluated
qualitatively.
Virtual drum vision test. Vision tests were performed using a virtual optomotor
system (Cerebral Mechanics)68. Mice were placed on an elevated platform in the
center of an area surrounded by four monitors. A cylinder comprised with a sine
wave grating was drawn in virtual three-dimensional space and rotated around the
animal. During testing, the behavior of the animal was tracked by a camera
mounted above. Lack of tracking the sine wave grating with reﬂexive head and neck
movements was indicative for an inability to resolve the visual pattern. A rando-
mized simple staircase test was used to quantify vision thresholds. Rotation speed
and contrast were set to 12.0 d/s and 100%, respectively.
Glucose tolerance test. The IpGTT was performed after 6 h of food withdrawal
on a fasting day. During the experiment, mice were kept separately in empty cages
without food or bedding. Body mass of mice was determined before food removal
and before the test was started. To determine the basal blood glucose level in the
unfed state, a small drop of blood obtained by cutting the tip of the tail was
analyzed with the Accu-Chek Aviva glucose analyzer (Roche). Subsequently, 2 g
glucose/kg body mass was injected intraperitoneally using a sterile 20% glucose
solution (B. Braun). We measured blood glucose levels in samples collected at
several time points after injection (15, 30, 60, and 120 min). After completion of the
experiment, mice were placed in their home cage with water and food available AL.
Blood collection. Mice were anesthetized with isoﬂurane and their retro-bulbar
sinus was punctured with non-heparinized glass capillaries (1.0 mm in diameter;
Neolab) to collect blood samples. For measurements after fasting, blood samples
were taken after a 6 h food withdrawal on a fasting day and collected in heparinized
sample tubes (Li-heparin, #078028, KABE). For measurements in the fed state,
blood samples collected from fed mice were divided into two portions. The major
portion was collected in a heparinized tube (Li-heparin, KABE). The smaller
portion was collected (using the same capillary) in an EDTA-coated tube (KABE,
#078035). Each tube was immediately inverted ﬁve times to achieve a homo-
geneous distribution of the anticoagulant. Li-heparin-coated tubes were stored at
room temperature for 1-2 h. Afterwards, cells and plasma were separated by a
centrifugation step (10 min, 5000 × g, 8 °C). Plasma was used for the immunology
experiments (30 µl; immunoglobulin concentrations) and the clinical chemistry
assessment (110 µl). The cell pellet was used for FACS-based immunology screen
(i.e., quantitative assessment of peripheral blood leukocyte populations). Plasma
samples for the clinical chemistry analyses were transferred into an Eppendorf tube
and either used directly (plasma of unfed mice) or diluted 1:2 with distilled water
(fed mice). The solution was mixed for a few seconds to prevent clotting and was
then centrifuged again (10 min, 5000 × g, 8 °C). The EDTA blood samples were
used for hematological analyses and kept on a rotary agitator at room temperature
prior to analysis.
Clinical chemistry. Clinical chemistry parameters were assessed using a Beckman
Coulter AU 480 auto-analyzer with few exceptions. Concentrations of free fatty
acids were measured using a kit from Wako Chemicals GmbH (NEFA-HR2, Wako
Chemicals) and levels of glycerol were analyzed employing a kit from Randox
Laboratories. A broad set of parameters was measured including various enzyme
activities, as well as plasma concentrations of speciﬁc substrates and electrolytes in
fed mice (alkaline phosphatase (ALP; EC 3.1.3.1), α-amylase (EC 3.2.1.1),
aspartate-aminotransferase (ASAT/GOT; EC 2.6.1.1), alanine-aminotransferase
(ALAT/GPT; EC 2.6.1.2), lactate dehydrogenase (LDH; EC 1.1.1.27), total protein,
albumin, glucose, lactate, fructosamine, cholesterol, triglycerides, urea, potassium,
sodium, chloride, calcium, inorganic phosphate, iron, and unsaturated iron-
binding capacity). For determination of clinical chemistry parameters in the fed
state, blood was taken from all animals in the morning of a regular fasting day
immediately after food withdrawal (i.e., both EOD and control mice had free access
to food prior to blood collection). Another set of parameters was determined in
samples derived from mice after a 6-h food withdrawal on a fasting day (i.e., both
EOD and control mice were food deprived for 6 h prior to blood collection):
Cholesterol, triglycerides, glucose, glycerol, non-esteriﬁed fatty acids (NEFA), high-
density lipoprotein (HDL) cholesterol. Plasma concentration of non-HDL cho-
lesterol was calculated. In addition, plasma insulin levels were determined in these
samples by conventional ELISA (Mercodia ultrasensitive mouse insulin ELISA,
Mercodia).
Hematology. A measure of 50 µl EDTA blood was diluted 1:5 in 200 μl of Sysmex
Cell-Pack buffer preﬁlled tubes (Sysmex, Art.No. 99940020) and was used to
determine complete blood cell counts using Sysmex XT2000iV. This device is a
hematology analyzer combining electrical impedance technique, ﬂuorescence
staining, and ﬂow cytometry to determine number and size of the different blood
cells and to distinguish erythrocytes and reticulocytes as well as different types of
leukocytes. MCV, mean platelet volume (MPV), PDW, and RDW were calculated
directly from the cell volume measurements. HCT was determined by multiplying
the MCV with the RBC count. Mean corpuscular hemoglobin (MCH) and mean
corpuscular hemoglobin concentrations (MCHC) were calculated by dividing
hemoglobin/RBC count (MCH) and hemoglobin/HCT (MCHC), respectively.
Platelet large cell ratio (PLCR) was deﬁned as the proportion of large platelets (>12
ﬂ). PCT was calculated by multiplying the MPV with the platelet count. Parameters
analyzed were: number of white blood cells (WBC), number of RBC, number of
platelets (PLT), hemoglobin concentration (HGB), HCT, MCV, MCH,MCHC,
RDW, MPV, PDW, PLCR (>12 ﬂ), and PCT.
FACS-based analysis of peripheral blood leukocytes (PBLs). PBLs were proﬁled
from 20 µl whole blood per mouse. Each whole-blood sample was incubated at
4–10 °C for 5 min with Fc block (clone 2.4G2). The antibody mix was added
afterwards and incubated at 4–10 °C for 40–60 min. Next, erythrocytes were lysed
and a formalin-based ﬁxation step was performed (BD FACS Lysing solution,
Becton Dickinson). Finally, after washing with FACS staining buffer (PBS, 0.5 %
BSA, 0.02 % sodium azide, pH 7.45), samples were analyzed on a 96-well plate
using a HyperCyt sampler (IntelliCyt) and a ten-color ﬂow cytometer (Gallios,
Beckman Coulter). The acquisition threshold was set on the CD45-channel. A total
number of 10,000–50,000 leukocytes per sample was examined. A software-based
analysis (Flowjo, TreeStar) was used to quantify individual PBL frequencies. Gates
for each parameter were based on “ﬂuorescence minus one” controls69. FACS
gating strategies are described in Supplementary Figs. 2–4.
The following main leukocyte populations were examined: B1 cells (CD5+,
CD19+B220+), B2 cells (CD5−, CD19+B220+), T cells (CD3+CD5+), granulocytes
(CD11b+Ly6G+), NK cells (CD3−CD5−, NKp46+, and/or NK1.1+), NKT cells (CD3
+CD5+, NKp46+, and/or NK1.1+), monocytes (non-lymphocytes, non-
granulocytes, and CD11b+). The following monocyte subpopulations were
analyzed: CD11c (positive or negative), Ly6C (high, medium, and negative). The
T-cell population (T cells are deﬁned as CD3+CD5+ and NKp46−NK1.1−) was
subdivided based on the expression of Ly6C. B-cell (CD19+B220+) populations
were subdivided according to the expression of CD11b and Ly6C. NK cell
populations were subdivided based on the expression of CD11b, CD11c, and Ly6C.
Immunoglobulin concentrations. The plasma level of IgE was analyzed using a
classical immunoassay isotype-speciﬁc sandwich ELISA (BD Pharmingen).
TEWL. TEWL measurements were performed in order to assess the quantity of
water lost via diffusion and evaporation to the surrounding atmosphere. Mouse
skin was assessed non-invasively with a special Tewameter (AquaFlux AF200)
placed on the skin. TEWL (g/(m2h)) was recorded over a short time period of 60-
90 s.
Micro-CT imaging and analysis. Tibiae from young and aged mice were imaged
using a SkyScan 1172 micro-CT scanner (Bruker) at 7.88 μm pixel resolution using
80 kV voltage, 100 mA current, and a 0.5 mm aluminum ﬁlter. The resulting
projection images were reconstructed with SkyScan’s NRECON package using a
uniform attenuation coefﬁcient, and analyzed using CTAn v.1.15. Cortical bone
architecture in the distal tibia (197 µm from 25 slices halfway between the tibia-
ﬁbula junction and the distal end of the tibia) was evaluated, and relevant bone
parameters (total tissue area, bone area, marrow area, cortical thickness, polar
moment of inertia) were selected for further data analysis.
Pathology. After being killed via CO2, mice were analyzed macroscopically and
weighed (http://eulep.pdn.cam.ac.uk/Necropsy_of_the_Mouse/index.php). All
organs (skin, heart, muscle, lung, brain, cerebellum, thymus, spleen, cervical lymph
nodes, thyroid, parathyroid, adrenal gland, stomach, intestine, liver, pancreas,
kidney, reproductive organs, and urinary bladder) were taken, ﬁxed in 4% buffered
formalin and embedded in parafﬁn for later histological examination. Two-µm-
thick sections from each organ sample were generated and stained with hema-
toxylin and eosin, Periodic acid Schiff stain, Elastica van Gieson (EvG, Weigert’s
stain), and/or Movat pentachrome. Thereafter, all sections were scanned using a
virtual slide system (NanozoomerHT2.0; Hamamatsu) and evaluated by a board-
certiﬁed pathologist. In addition, specialized automated image segmentation soft-
ware (Deﬁniens Tissue Studio (Deﬁniens) and CellProﬁler70) was used to quantify
age-related tissue changes via computer-assisted analyses.
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RNA sequencing. Illumina next-generation sequencing libraries, generated from
high-quality input RNAs, were analyzed on an Illumina HiSeq2000 system (Illu-
mina) via 50 bp single end sequencing. Reads were quality and adapter trimmed
with custom software. The resulting fastq ﬁles were aligned with STAR against the
Ensembl GRCm38 reference genome. featureCounts was used on the resulting
BAM ﬁles to generate unique counts. Those results were then input into DESeq2
for further analysis. Ingenuity pathway analysis (Ingenuity Systems) was employed
for pathway analysis of differential expressed genes (FDR< 0.1). fastq and fea-
tureCounts ﬁles were deposited on NCBI’s gene expression omnibus (GEO) under
the accession code GSE96644.
Statistics. Unless stated otherwise, the data are presented as mean± SEM and
were analyzed by two-way ANOVAs with the between-subjects factors of age (old
vs. young) and DR (EOD vs. AL). Tukey post hoc tests were applied if appropriate.
Statistical analyses were carried out using GraphPad (version 6.07) and SPSS
(version 23). p< 0.05 was considered statistically signiﬁcant. *p< 0.05, **p < 0.01,
and ***p < 0.001.
Data availability. RNA sequencing data that support the ﬁndings of this study
have been deposited in GEO under accession code GSE96644. All other data that
support the ﬁndings of the current study are included within the article or the
associated supplementary material.
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